Switch to:
More From Other Websites
Novavax starts new clinical trial in bid to prove failed RSV vaccine Jan 19 2017
Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults Jan 19 2017
4:06 pm Novavax announces the initiation of a Phase 2 clinical trial of its respiratory syncytial... Jan 19 2017
Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults Jan 19 2017
In Honor Of Friday The 13th, Here Are Some Of The Unluckiest Trades Of 2016 Jan 13 2017
D.C.-area biotech stocks fall on Trump's tough talk on industry Jan 11 2017
Novavax, Inc. – Value Analysis (NASDAQ:NVAX) : January 10, 2017 Jan 10 2017
Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : January 9, 2017 Jan 09 2017
5 Stocks Setting Up for Big Breakouts Jan 06 2017
Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 05 2017
Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 05 2017
Genocea Announces Positive 6-Month Results from GEN-003 Phase 2b Clinical Trial Jan 05 2017
ETFs with exposure to Novavax, Inc. : January 3, 2017 Jan 03 2017
Are Options Traders Betting on a Big Move in Novavax (NVAX) Stock? Dec 28 2016
ETFs with exposure to Novavax, Inc. : December 21, 2016 Dec 21 2016
Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : December 21, 2016 Dec 21 2016
Why Novavax (NVAX) Stock Might be a Great Pick Dec 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK